Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


06.11.2017

1 Am J Hematol
5 Ann Hematol
1 Biochem Biophys Res Commun
3 Blood
2 Br J Haematol
2 Cancer
1 Cancer Lett
1 Hematol Oncol Clin North Am
3 Int J Hematol
3 J Clin Oncol
8 J Pediatr Hematol Oncol
2 Leuk Lymphoma
4 Leuk Res
3 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. SANDMAIER BM, Khaled S, Oran B, Gammon G, et al
    Results of a Phase 1 Study of Quizartinib as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Remission Following Allogeneic Hematopoietic Stem Cell Transplant.
    Am J Hematol. 2017 Nov 1. doi: 10.1002/ajh.24959.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. LORENZANA N, Avila LF, Alonso S, Colado E, et al
    The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment.
    Ann Hematol. 2017;96:1833-1840.
    PubMed     Text format     Abstract available

  3. ZHANG X, Li B, Yu J, Dahlstrom J, et al
    MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.
    Ann Hematol. 2017 Oct 27. doi: 10.1007/s00277-017-3158.
    PubMed     Text format     Abstract available

  4. YANG D, Zhang X, Zhang X, Xu Y, et al
    The progress and current status of immunotherapy in acute myeloid leukemia.
    Ann Hematol. 2017 Oct 28. doi: 10.1007/s00277-017-3148.
    PubMed     Text format     Abstract available

  5. NAGEL G, Weber D, Fromm E, Erhardt S, et al
    Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).
    Ann Hematol. 2017 Oct 31. doi: 10.1007/s00277-017-3150.
    PubMed     Text format     Abstract available

  6. NASSEREDDINE S, Lap CJ, Haroun F, Tabbara I, et al
    The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia.
    Ann Hematol. 2017 Oct 31. doi: 10.1007/s00277-017-3161.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. BAILON E, Aguilera-Montilla N, Gutierrez-Gonzalez A, Ugarte-Berzal E, et al
    A catalytically inactive gelatinase B/MMP-9 mutant impairs homing of chronic lymphocytic leukemia cells by altering migration regulatory pathways.
    Biochem Biophys Res Commun. 2017 Oct 25. pii: S0006-291X(17)32107.
    PubMed     Text format     Abstract available


    Blood

  8. SERAFIN V, Capuzzo G, Milani G, Minuzzo SA, et al
    Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
    Blood. 2017 Nov 3. pii: blood-2017-05-784603. doi: 10.1182/blood-2017-05-784603.
    PubMed     Text format     Abstract available

  9. MOLICA S, Giannarelli D, Mirabelli R, Levato L, et al
    Chronic lymphocytic leukemia international prognostic index (CLL-IPI): a systematic review and meta-analysis.
    Blood. 2017 Oct 30. pii: blood-2017-09-806034. doi: 10.1182/blood-2017-09-806034
    PubMed     Text format    

  10. KATAOKA K, Iwanaga M, Yasunaga JI, Nagata Y, et al
    Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
    Blood. 2017 Oct 30. pii: blood-2017-01-761874. doi: 10.1182/blood-2017-01-761874
    PubMed     Text format     Abstract available


    Br J Haematol

  11. WU B, Slabicki M, Sellner L, Dietrich S, et al
    MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
    Br J Haematol. 2017;179:421-429.
    PubMed     Text format     Abstract available

  12. KOHNKE T, Wittmann VK, Bucklein VL, Lichtenegger F, et al
    Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
    Br J Haematol. 2017;179:480-487.
    PubMed     Text format     Abstract available


    Cancer

  13. KANTARJIAN HM, Mamolo CM, Gambacorti-Passerini C, Cortes JE, et al
    Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31082.
    PubMed     Text format     Abstract available

  14. FRICK MA, Vachani CC, Bach C, Hampshire MK, et al
    Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plans.
    Cancer. 2017;123:4268-4276.
    PubMed     Text format     Abstract available


    Cancer Lett

  15. WEN S, Wang J, Liu P, Li Y, et al
    Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
    Cancer Lett. 2017 Oct 22. pii: S0304-3835(17)30650.
    PubMed     Text format     Abstract available


    Hematol Oncol Clin North Am

  16. ROSE-INMAN H, Kuehl D
    Acute Leukemia.
    Hematol Oncol Clin North Am. 2017;31:1011-1028.
    PubMed     Text format     Abstract available


    Int J Hematol

  17. COOK LB, Rowan AG, Demontis MA, Sagawe S, et al
    Long-term clinical remission maintained after cessation of zidovudine and interferon-alpha therapy in chronic adult T-cell leukemia/lymphoma.
    Int J Hematol. 2017 Oct 31. doi: 10.1007/s12185-017-2361.
    PubMed     Text format     Abstract available

  18. NAKAMAE H, Fukuda T, Nakaseko C, Kanda Y, et al
    Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial.
    Int J Hematol. 2017 Oct 26. doi: 10.1007/s12185-017-2353.
    PubMed     Text format     Abstract available

  19. TAKEUCHI J, Kusumoto S, Akiyama H, Kanda Y, et al
    JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
    Int J Hematol. 2017 Oct 24. doi: 10.1007/s12185-017-2350.
    PubMed     Text format    


    J Clin Oncol

  20. LIM EL, Trinh DL, Ries RE, Wang J, et al
    MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
    J Clin Oncol. 2017 Oct 25:JCO2017747451. doi: 10.1200/JCO.2017.74.7451.
    PubMed     Text format     Abstract available

  21. CORTES JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, et al
    Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
    J Clin Oncol. 2017 Nov 1:JCO2017747162. doi: 10.1200/JCO.2017.74.7162.
    PubMed     Text format     Abstract available

  22. OPAT S, Hawkes EA
    Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.
    J Clin Oncol. 2017 Nov 3:JCO2017754721. doi: 10.1200/JCO.2017.75.4721.
    PubMed     Text format    


    J Pediatr Hematol Oncol

  23. RAO Y, Wu Y, Dong A, Zhu K, et al
    Disseminated Nonleukemic Myeloid Sarcoma of the Spleen With Involvement of the Liver in an Infant.
    J Pediatr Hematol Oncol. 2017;39:e233-e235.
    PubMed     Text format     Abstract available

  24. EROGLU N, Bahadir A, Erduran E
    A Case of ALL Developing Posterior Reversible Encephalopathy Secondary to Hyponatremia.
    J Pediatr Hematol Oncol. 2017;39:e476-e478.
    PubMed     Text format     Abstract available

  25. CHEYUO C, Radwan W, Ahn J, Gyure K, et al
    Biallelic PMS2 Mutation and Heterozygous DICER1 Mutation Presenting as Constitutional Mismatch Repair Deficiency With Corpus Callosum Agenesis: Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2017;39:e381-e387.
    PubMed     Text format     Abstract available

  26. SHAUKAT H, O'Mara J, Neier M
    A Pediatric Case of Persistent Thrombocytopenia in a Patient Who Developed All.
    J Pediatr Hematol Oncol. 2017;39:e512-e514.
    PubMed     Text format     Abstract available

  27. KIZILOCAK H, Dikme G, Ozdemir N, Kurugoglu S, et al
    Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
    J Pediatr Hematol Oncol. 2017;39:e373-e376.
    PubMed     Text format     Abstract available

  28. KIM MJ, Nasr A, Kabir B, de Nanassy J, et al
    Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
    J Pediatr Hematol Oncol. 2017;39:528-537.
    PubMed     Text format     Abstract available

  29. DANG BN, De Oliveira S, Bowles L, Moore TB, et al
    Isolated Testicular Recurrence of AML in Patients With Chronic GVHD >1 Year Following Allogeneic Stem Cell Transplant.
    J Pediatr Hematol Oncol. 2017;39:e423-e425.
    PubMed     Text format     Abstract available

  30. MOSAKHANI N, Missiry ME, Vakkila E, Knuutila S, et al
    Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017;39:585-588.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  31. SATO R, Jacob J, Gaballa S
    Rapid flare of immune thrombocytopenia after stopping ibrutinib in a patient with chronic lymphocytic leukemia.
    Leuk Lymphoma. 2017 Oct 30:1-4. doi: 10.1080/10428194.2017.1387907.
    PubMed     Text format    

  32. MCCURDY SR, Levis MJ
    Emerging molecular predictive and prognostic factors in acute myeloid leukemia.
    Leuk Lymphoma. 2017 Nov 2:1-19. doi: 10.1080/10428194.2017.1393669.
    PubMed     Text format     Abstract available


    Leuk Res

  33. ERIKSSON A, Chantzi E, Fryknas M, Gullbo J, et al
    Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.
    Leuk Res. 2017;63:41-46.
    PubMed     Text format     Abstract available

  34. ZHAO WH, Huang BT, Zhang JY, Zeng QC, et al
    Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines.
    Leuk Res. 2017;63:28-33.
    PubMed     Text format     Abstract available

  35. FAKHIMAHMADI A, Nazmi F, Rahmati M, Bonab NM, et al
    Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy.
    Leuk Res. 2017;63:15-21.
    PubMed     Text format     Abstract available

  36. KRUG U, Gale RP, Berdel WE, Muller-Tidow C, et al
    Therapy of older persons with acute myeloid leukaemia.
    Leuk Res. 2017;60:1-10.
    PubMed     Text format     Abstract available


    Leukemia

  37. SAID B, Gilles S, Weisdorf D, Rashidi A, et al
    The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia.
    Leukemia. 2017 Oct 31. doi: 10.1038/leu.2017.
    PubMed     Text format    

  38. LHERMITTE L, Mejstrikova E, van der Sluijs-Gelling AJ, Grigore GE, et al
    Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia.
    Leukemia. 2017 Nov 1. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  39. WALF-VORDERWULBECKE V, Pearce K, Brooks T, Hubank M, et al
    Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
    Leukemia. 2017 Nov 1. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: